| Style | Citing Format |
|---|---|
| MLA | Vanaki N, et al.. "Distinct Decidualization and Senomorphic Responses in Endometrial Vs. Menstrual Blood Stem/Stromal Cells: Implications for Reproductive Therapies." Stem Cell Research and Therapy, vol. 17, no. 1, 2026, pp. -. |
| APA | Vanaki N, Tavangar B, Darzi M, Arefi S, Mirzadegan E, Mousavi M, Shokri F, Zarnani A H (2026). Distinct Decidualization and Senomorphic Responses in Endometrial Vs. Menstrual Blood Stem/Stromal Cells: Implications for Reproductive Therapies. Stem Cell Research and Therapy, 17(1), -. |
| Chicago | Vanaki N, Tavangar B, Darzi M, Arefi S, Mirzadegan E, Mousavi M, Shokri F, Zarnani A H. "Distinct Decidualization and Senomorphic Responses in Endometrial Vs. Menstrual Blood Stem/Stromal Cells: Implications for Reproductive Therapies." Stem Cell Research and Therapy 17, no. 1 (2026): -. |
| Harvard | Vanaki N et al. (2026) 'Distinct Decidualization and Senomorphic Responses in Endometrial Vs. Menstrual Blood Stem/Stromal Cells: Implications for Reproductive Therapies', Stem Cell Research and Therapy, 17(1), pp. -. |
| Vancouver | Vanaki N, Tavangar B, Darzi M, Arefi S, Mirzadegan E, Mousavi M, et al.. Distinct Decidualization and Senomorphic Responses in Endometrial Vs. Menstrual Blood Stem/Stromal Cells: Implications for Reproductive Therapies. Stem Cell Research and Therapy. 2026;17(1):-. |
| BibTex | @article{ author = {Vanaki N and Tavangar B and Darzi M and Arefi S and Mirzadegan E and Mousavi M and Shokri F and Zarnani A H}, title = {Distinct Decidualization and Senomorphic Responses in Endometrial Vs. Menstrual Blood Stem/Stromal Cells: Implications for Reproductive Therapies}, journal = {Stem Cell Research and Therapy}, volume = {17}, number = {1}, pages = {-}, year = {2026} } |
| RIS | TY - JOUR AU - Vanaki N AU - Tavangar B AU - Darzi M AU - Arefi S AU - Mirzadegan E AU - Mousavi M AU - Shokri F AU - Zarnani A H TI - Distinct Decidualization and Senomorphic Responses in Endometrial Vs. Menstrual Blood Stem/Stromal Cells: Implications for Reproductive Therapies JO - Stem Cell Research and Therapy VL - 17 IS - 1 SP - EP - PY - 2026 ER - |